Functionally, adiponectin plays a role in the suppression of body disturbances coupled with metabolic syndrome, such as obesity, atherosclerosis, non-alcoholic fatty liver disease, and diabetes, and thus it exerts a wide range of beneficial effects on the cardiovascular system [36]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.